NYKODE THERAPEUTICS ASA (NYKD.OL) Forecast, Price Target & Analyst Ratings

OSL:NYKD • NO0010714785

Current stock price

2.97 NOK
-0.17 (-5.41%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NYKODE THERAPEUTICS ASA (NYKD.OL).

Forecast Snapshot

Consensus Price Target

Price Target
NOK4.59
+ 54.55% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 27, 2026
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
NOK4.59
Upside
+ 54.55%
From current price of NOK2.97 to mean target of NOK4.59, Based on 7 analyst forecasts
Low
NOK4.55
Median
NOK4.59
High
NOK4.73

Price Target Revisions

1 Month
104.55%
3 Months
-15.89%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for NYKD.OL. The average price target is 4.59 NOK. This implies a price increase of 54.55% is expected in the next year compared to the current price of 2.97.
The average price target has been revised downward by 15.89% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

NYKD Current Analyst RatingNYKD Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

NYKD Historical Analyst RatingsNYKD Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
NYKD.OL was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NYKD.OL.
In the last month the buy percentage rose by 41 points. So the trust of analysts is improving.
NYKD.OL was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 27, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
NYKD.OL revenue by date.NYKD.OL revenue by date.
7.168M
-78.89%		12.902M
79.99%		8.679M
-32.73%		1.02M
-100.00%		17.85M4.217M
-76.38%		705.78M
16,636.54%		2.537B
259.46%		5.998B
136.42%
EBITDA
YoY % growth
NYKD.OL ebitda by date.NYKD.OL ebitda by date.
-48.85M
-598.76%		-54.237M
-11.03%		-44.88M
17.25%		-29.07M
40.84%		-28.05M-8.67M
69.09%		-177.091M
-1,942.57%		-596.779M
-236.99%		942.33M
257.90%		2.647B
180.90%
EBIT
YoY % growth
NYKD.OL ebit by date.NYKD.OL ebit by date.
-50.664M
-555.84%		-56.359M
-11.24%		-47.131M
16.37%		-29.07M
39.34%		-27.03M-10.71M
60.38%		-265.637M
-2,380.27%		-668.349M
-151.60%		-35.235M
94.73%		2.555B
7,351.41%
Operating Margin
NYKD.OL operating margin by date.NYKD.OL operating margin by date.
-706.81%-436.82%-543.05%-2,850.00%N/A-60.00%-6,299.18%-94.70%-1.39%42.60%
EPS
YoY % growth
NYKD.OL eps by date.NYKD.OL eps by date.
N/A
-1,364.33%		-0.12
19.66%		-0.12
-0.18%		-0.04
70.24%		-0.08-0.03
60.00%		-1.05
-3,345.00%		-1.54
-46.19%		-0.11
92.86%		3.78
3,536.70%

Reported data in USD, estimates in NOK

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

NYKD.OL Yearly Revenue EstimatesNYKD.OL Yearly Revenue EstimatesYearly Revenue Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
NYKD.OL Yearly EPS VS EstimatesNYKD.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 -1 2 3

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-209.09%
EPS Next 5 Year
-25.25%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
60.50%
Revenue Next 5 Year
377.69%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-82.63%
EBIT Next 5 Year
102.93%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

NYKODE THERAPEUTICS ASA / NYKD.OL Forecast FAQ

What is the average price target for NYKODE THERAPEUTICS ASA (NYKD.OL) stock?

7 analysts have analysed NYKD.OL and the average price target is 4.59 NOK. This implies a price increase of 54.55% is expected in the next year compared to the current price of 2.97.

When does NYKODE THERAPEUTICS ASA (NYKD.OL) report earnings?

NYKODE THERAPEUTICS ASA (NYKD.OL) will report earnings on 2026-05-27.

What is the expected long term growth rate for NYKODE THERAPEUTICS ASA (NYKD.OL)?

The expected long term growth rate for NYKODE THERAPEUTICS ASA (NYKD.OL) is 60.5%.